 |
Video: What is a Stock Split?
|
 |
| Caladrius Biosciences is a clinical-stage biopharmaceutical company focused on the development of treatments and reversal of severe diseases. Co.'s product candidates include: XOWNA®, which is a Phase 2a study and an ongoing follow-on Phase 2b study in the U.S. for the treatment of coronary microvascular dysfunction; HONEDRA®, which is eligible for early conditional approval in Japan for the treatment of critical limb ischemia based on the results of a clinical trial; and CLBS201, which is designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients with chronic kidney disease related to type 2 diabetes. According to our CLBS split history records, CLBS has had 1 split. | |
 |

CLBS (CLBS) has 1 split in our CLBS split history database. The split for CLBS took place on July 28, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of CLBS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as CLBS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CLBS split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CLBS shares, starting with a $10,000 purchase of CLBS, presented on a split-history-adjusted basis factoring in the complete CLBS split history.

Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/20/2016 |
|
| End date: |
09/14/2022 |
|
| Start price/share: |
$4.90 |
|
| End price/share: |
$0.43 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-91.22% |
|
| Average Annual Total Return: |
-32.30% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$877.31 |
|
| Years: |
6.24 |
|
|
 |
| Date |
Ratio |
| 07/28/2016 | 1 for 10 |
|
 |